EpiGen is governed by a stakeholder approved Consortium Agreement, and its members report to a Board comprising representatives of each partner institution. The Board guides the strategic direction and development of EpiGen and has overall responsibility for the operation and management of EpiGen. The Science Management Group (SMG) determines the scientific direction of the Consortium. The EpiGen Scientific Advisory Board (SAB) is comprised of a group of senior academics who have expertise in research fields related to EpiGen’s Mission; they advise both the SMG and the Board on EpiGen's scientific strategy. The operational Intellectual Property and Contracts Management Group (IPCMG) is chaired by the Head of Operations. This group comprises the Clinical Trial Operations Director, EpiGen Project Managers, project-specific Project Managers (such as the NiPPeR Clinical Trial Project Managers), Legal advisors and Finance Managers.